Pulmonx (LUNG) AGM 2026 summary

Opening remarks and agenda

• Meeting opened by the CEO, expressing gratitude to employees and shareholders and outlining the mission to lead in severe lung disease solutions.

• Introduction of board members, executive team, and independent auditor; meeting held virtually and recorded for later access.

• Agenda included opening of polls, voting on proposals, and Q&A for shareholder questions relevant to the meeting.

Board and executive committee updates

• Board members and executive officers present were introduced, including the chairman, COO/CFO, and General Counsel.

• Independent auditor from BDO USA was introduced as present for the meeting.

Shareholder proposals

• Three proposals presented: election of three Class III directors, ratification of BDO USA as auditor for 2026, and a non-binding advisory vote on executive compensation.

• Nominees for Class III directors were Thomas W. Burns, Georgia Garinois-Melenikiotou, and Dana G. Mead, Jr.